Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and Its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects
Open Access
- 14 January 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2), 520
- https://doi.org/10.3390/ijms21020520
Abstract
There is recent evidence that the dysfunctional responses of a peculiar visceral fat deposit known as epicardial adipose tissue (EAT) can directly promote cardiac enlargement in the case of obesity. Here, we observed a newer molecular pattern associated with LV dysfunction mediated by prostaglandin E2 (PGE2) deregulation in EAT in a cardiovascular disease (CVD) population. A series of 33 overweight CVD males were enrolled and their EAT thickness, LV mass, and volumes were measured by echocardiography. Blood, plasma, EAT, and SAT biopsies were collected for molecular and proteomic assays. Our data show that PGE2 biosynthetic enzyme (PTGES-2) correlates with echocardiographic parameters of LV enlargement: LV diameters, LV end diastolic volume, and LV masses. Moreover, PTGES-2 is directly associated with EPAC2 gene (r = 0.70, p < 0.0001), known as a molecular inducer of ST2/IL-33 mediators involved in maladaptive heart remodelling. Furthermore, PGE2 receptor 3 (PTEGER3) results are downregulated and its expression is inversely associated with ST2/IL-33 expression. Contrarily, PGE2 receptor 4 (PTGER4) is upregulated in EAT and directly correlates with ST2 molecular expression. Our data suggest that excessive body fatness can shift the EAT transcriptome to a pro-tissue remodelling profile, may be driven by PGE2 deregulation, with consequent promotion of EPAC2 and ST2 signalling.This publication has 44 references indexed in Scilit:
- Epac proteins: specific ligands and role in cardiac remodellingBiochemical Society Transactions, 2014
- Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokinesEuropean Heart Journal, 2014
- A Role for Soluble ST2 in Vascular Remodeling Associated with Obesity in RatsPLOS ONE, 2013
- Prostaglandin E2 Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin SecretionDiabetes, 2013
- Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissueInternational Journal of Obesity, 2012
- The importance of dietary modulation of cAMP and insulin signaling in adipose tissue and the development of obesityAnnals of the New York Academy of Sciences, 2010
- Echocardiographic Epicardial Fat: A Review of Research and Clinical ApplicationsJournal of the American Society of Echocardiography, 2009
- Threshold Values of High‐risk Echocardiographic Epicardial Fat ThicknessObesity, 2008
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJCI Insight, 2007
- Relation between epicardial adipose tissue and left ventricular massThe American Journal of Cardiology, 2004